SCHEMBL119275

SCHEMBL119275

NC[C@H](O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL250581 1.00
SCHEMBL33836 1.00
SCHEMBL1193808 1.00 LMNA (0.57)
SCHEMBL26111721 1.00 LMNA (0.57)
Water SCHEMBL9635107 0.96 LMNA (0.53)
Hydrochloric Acid SCHEMBL7384488 0.96
Hydrochloric Acid SCHEMBL1026446 0.96
SCHEMBL11348902 0.96
Fluoride SCHEMBL4617479 0.96
Water SCHEMBL2821624 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118507104-B Low-temperature conductive silver paste and preparation method thereof 常州碳禾新材料科技有限公司 2024-09-20 CN claimed
CN-118507104-A Low-temperature conductive silver paste and preparation method thereof 常州碳禾新材料科技有限公司 2024-08-16 CN claimed
CN-117558983-B Low-temperature electrolyte, preparation method and lithium battery 广东聚圣科技有限公司 2024-06-21 CN claimed
CN-117558983-A Low-temperature electrolyte, preparation method and lithium battery 广东聚圣科技有限公司 2024-02-13 CN claimed
CN-111956809-B Nucleic acid biological medicine, preparation method thereof and application thereof in tumor treatment 湖南大学 2022-11-01 CN claimed
CN-111956809-A Nucleic acid biological medicine, preparation method thereof and application thereof in tumor treatment 湖南大学 2020-11-20 CN claimed
EP-1973917-B1 PROTEIN KINASE INHIBITORS ABBVIE INC (US) 2015-06-10 EP claimed
US-8604051-B2 Thieno-pyridine derivatives as MEK inhibitors UCB PHARMA S.A. (BE) 2013-12-10 US claimed
US-20130150573-A1 THIENO-PYRIDINE DERIVATIVES AS MEK INHIBITORS UCB PHARMA S.A. (BE) 2013-06-13 US claimed
US-8394822-B2 Thieno-pyridine derivatives as MEK inhibitors UCB PHARMA, S.A. (BE) 2013-03-12 US claimed
CN-1558898-A Antiviral agent ��Ұ����ҩ��ʽ���� 2004-12-29 CN claimed
EP-1307447-B1 3-INDOLYL-4-PHENYL-1H-PYRROLE-2,5-DIONE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE KINASE-3BETA HOFFMANN LA ROCHE (CH) 2004-12-15 EP claimed
WO-2004060887-A1 METHOD FOR PRODUCING 5-CHLORO-N-({5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)-PHENYL]-1,3-OXAZOLIDIN-5-YL}-METHYL)-2-THIOPHENE CARBOXAMIDE BAYER HEALTHCARE AG (DE) 2004-07-22 WO claimed
EP-1422218-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2004-05-26 EP claimed
EP-1307447-A2 3-INDOLYL-4-PHENYL-1H-PYRROLE-2,5-DIONE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE KINASE-3BETA F. HOFFMANN-LA ROCHE AG (CH) 2003-05-07 EP claimed
US-20020188018-A1 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta GONG LEYI (US) 2002-12-12 US claimed
US-6479490-B2 TREATMENT OF DISEASES CHARACTERIZED BY EXCESS TH2 CYTOKINES AND/ OR AN EXCESS IGE PRODUCTION. SYNTEX (U.S.A.) LLC 2002-11-12 US claimed
US-20020052397-A1 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta SYNTEX (U.S.A.) LLC 2002-05-02 US claimed
WO-2002010158-A2 3-INDOLYL-4-PHENYL-1H-PYRROLE-2,5-DIONE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE KINASE-3BETA F. HOFFMANN-LA ROCHE AG (CH) 2002-02-07 WO claimed
US-3962338-A Novel methods and compounds employed therein MERCK & CO., INC. (US) 1976-06-08 US claimed